Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 390

Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Condition:   Central Nervous System Neoplasms
Intervention:   Drug: ONC206
Sponsors:   Oncoceutics, Inc.;   National Institutes of Health (NIH)
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 19, 2020 / by / in
Comments